Skip to main content

Strontium Ranelate

  • Chapter
Osteoporosis
  • 2428 Accesses

Strontium is a divalent cation that is closely chemically related to calcium. Strontium ranelate contains two atoms of stable strontium and an organic moiety (ranelic acid). Strontium increases pre-osteoblast replication, osteoblast differentiation, collagen type 1 synthesis and bone matrix mineralization (Fig. 18.1). In low doses strontium increases the density of the spongy bone. It reduces resorption and stimulates formation of bone, leading to a gain in bone mass and improved bone mechanical properties (Fig. 18.2). In other words, strontium uncouples the activity of the osteoclasts and osteoblasts, in favour of bone formation! Ongoing investigations of its activities have revealed other actions, whose overall effects include improvements in bone geometry, cortical bone thickness, trabecular bone morphology among other effects on bone quality, all of which enhance the strength of the bones. This has been confirmed in human trials with increased bone-specific alkaline phosphatase (a marker of bone formation) and decreased C-terminal peptide (a marker of bone resorption). The increment in bone density is comparable to that achieved by fluoride: up to 20%.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Chapter 18 Strontium Ranelate

  1. Ammann P (2005) Strontium ranelate: a novel mode of action leading to renewed bone quality. Osteoporos Int 16:S11–S15

    Article  PubMed  CAS  Google Scholar 

  2. Fuleihan G (2004) Strontium Ranelate – a novel therapy for osteoporosis or a permutation of the same? N Engl J Med 350:504–506

    Article  CAS  Google Scholar 

  3. Marie P (2003) Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate. Osteoporos Int 14(Suppl 3):S9–S12

    PubMed  CAS  Google Scholar 

  4. Marie P (2005) Strontium ranelate: a novel mode of action optimizing bone formation and resorption. Osteoporos Int 16:S7–S10

    Article  PubMed  CAS  Google Scholar 

  5. Meunier P, Roux C, Seeman E et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468

    Article  PubMed  CAS  Google Scholar 

  6. Reginster J, Meunier P (2003) Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies. Osteoporos Int 14(Suppl 3): S56–S65

    PubMed  CAS  Google Scholar 

  7. Seeman E, Devogelaer J, Lorenc R et al. (2008) Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J Bone Miner Res 23:433–438

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bartl, R., Frisch, B. (2009). Strontium Ranelate. In: Osteoporosis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79527-8_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79527-8_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79526-1

  • Online ISBN: 978-3-540-79527-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics